BGM Group Ltd.
BGM | NASDAQ
$8.09
-$1.45 (-15.20%)
At close: Oct 30, 2026, 3:56 PM ET
$8.15
+$0.06 (+0.74%)
After-hours:
Oct 30, 2026, 7:30 PM ET
-15.20%
(1D)No price chart data available for 1D timeframe.
Rating
37.5
+9.0 ptsFundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #587/1028 (Top 57%)
Key Statistics
Market Data
Market Cap $102.64M
1D Range
8.00 8.96
52W Range
7.20 296.70
Valuation (TTM)
PE -1.67
PB 0.26
EV/EBITDA -9.98
Valuation (NTM)
Forward PE N/A
Forward PEG 0.00
Price Target $0.00
Cash Flow
FCF Yield 1.4%
SBC Adj. FCF Yield 1.4%
SBC Impact N/A
Margins
Gross Margin 12.8%
Operating Margin -23.4%
FCF Margin 3.0%
Growth (CAGR)
Revenue 3Y | 5Y -16.4% |
-5.4%
Dil EPS 3Y | 5Y 92.5% |
-93.6%
FCF 3Y | 5Y -13.8% |
-154.2%
Returns
ROA -4.8%
ROE -5.4%
ROIC -2.8%
Financial Health
Net Cash
$10.37M
Current Ratio 1.25
Interest Coverage -991.63
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Operating from Chengdu, People's Republic of China, BGM Group Ltd. engages in the manufacturing and supply of active pharmaceutical ingredients (APIs), traditional Chinese medicine (TCM) derivatives, ...
Sector Healthcare
Employees 298
IPO Date Jan 12, 2021
Website www.bgmgroupltd.com
Fiscal Year October - September
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove BGM